1. Inserm, Centre d’Investigations Cliniques- 1433, and Inserm U1116; CHRU Nancy; Université de Lorraine; Association Lorraine pour le Traitement de l’Insuffisance Rénale, Institut lorrain du Cœur et des Vaisseaux Louis Mathieu, 4 rue du Morvan, Nancy, France
2. F-CRIN INI-CRCT, Nancy, France
3. Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA
4. Richard L. Roudebush Veterans Administration Medical Center, Indianapolis, IN, USA
5. Fresenius Medical Care Deutschland and University of Montpellier, UFR Medicine, France
6. Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
7. AP-HP, Hôpital Européen Georges Pompidou, Unité de Recherche Clinique and INSERM CIC 1418, Paris, France
8. School of Public Health, The University of Sydney, New South Wales, Australia
9. Centre for Kidney Research, The Children's Hospital at Westmead, New South Wales, Australia
10. Preventive Medicine Section, Veterans Affairs Medical Center, Memphis, Tennessee, USA
11. Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands
12. Inserm U1018, Université Paris-Saclay, UVSQ, Université. Paris-Sud, Villejuif, France
13. Relypsa, Inc., Redwood City, CA, USA
14. AstraZeneca, Gaithersburg, MD, USA
15. Dutch Medicines Evaluation Board, Utrecht, The Netherlands
16. Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands
17. France Centre Hospitalier F.H. Manhès, Fleury-Merogis, France
18. Ambroise Pare University Hospital, APHP, Paris-Ile-de France-Ouest University (UVSQ), and INSERM U1018, Team 5 Boulogne Billancourt, France
19. U942 Inserm, Paris, France
20. University Paris Diderot, Sorbonne Paris Cité, Paris, France
21. APHP, Department of Anesthesia and Critical Care, Hôpitaux Universitaires Saint Louis-Lariboisière, Paris, France
22. Cardiovascular Division, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA, USA
23. National Heart, Lung, and Blood Institute, Bethesda, MD, USA
24. Institute of Investigation and Hypertension Unit, Hospital 12 de Octubre, Department of Preventive Medicine and Public Health, Universidad Autonoma and School of Doctoral Studies and Research, Universidad Europea de Madrid, Madrid, Spain
25. ACI Clinical, Bala Cynwyd, PA, USA
26. Sarfez Pharmaceuticals, Inc., McLean, VA, USA
27. ZS Pharma, San Mateo, CA, USA
28. AstraZeneca, Gothenburg, Sweden
29. Division of Cardiovascular and Renal Products, Center for Drug Evaluation and Research, Food and Drug Administration, Silver Spring, MD, USA
30. Campbell University College of Pharmacy and Health Sciences, NC, USA
31. Department of Cardiology, Aarhus University Hospital, Aarhus, Denmark
32. McMaster University and Population Health Research Institute, Hamilton, Canada
33. Division of Nephrology, Department of Internal Medicine 1, University Hospital Würzburg and Comprehensive Heart Failure Center, Würzburg, Germany
34. Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, USA
35. Hypertension, Kidney and Vascular Research Center and Division of Nephrology and Hypertension, Department of Medicine, Georgetown University, Washington, DC, USA
36. Statistics Collaborative, Inc., Washington, District of Columbia, USA
37. University of Michigan School of Medicine, Ann Arbor, MI, USA